Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2025

Summary of Significant Accounting Policies [Abstract]

Inventory Stated at Cost, Net of Reserve

Inventory stated at cost, consisted of the following as of December 31:

		2025	2024
Materials	$	2,060,521	1,308,863
Work in progress		1,266,542	982,630
Finished goods		2,413,186	754,830
Inventory	$	5,740,249	3,046,323

Other Assets

The Company has included these amounts on the accompanying balance sheets as follows as of December 31:

		2025	2024
Prepaid and other current assets	$	249,394	315,897
Other long-term assets		698,898	714,912
Research tax credits available to the Company	$	948,292	1,030,809

Estimated Useful Lives of Assets

Depreciation and amortization are computed using the straight‑line method over estimated useful lives of assets as follows:

Leasehold improvements	Shorter of lease term(s) or useful life
Office equipment	5 years
Furniture and fixtures	7 years
Machinery and equipment	5 to 7 years

Intangible Assets

Intangible assets consist of the following as of December 31:

		2025		2024
Cost	$	1,869,257		1,755,009
Accumulated amortization		(1,734,343	)	(1,689,091	)
Net book value	$	134,914		65,918

Accrued Expenses

Accrued expenses consisted of the following as of December 31:

		2025	2024
Incentive and other compensation costs	$	870,910	650,768
Clinical trial costs		259,293	354,762
Director fees		71,250	70,000
Other		64,320	75,519
Accrued expenses	$	1,265,773	1,151,049

Sales by Geographic Region

The following table summarizes the Company’s sales by geographic region for the years ending December 31:

Primary geographical markets		2025	2024
U.S.	$	1,393,555	1,073,508
International		899,758	555,600
Total	$	2,293,313	1,629,108